Clinical Approach to Recurrent Voiding Dysfunction, Dysuria, and Pelvic Pain Persisting for at Least 3 Months

키워드

참고문헌 (65)

1. Aguiar LM, "Bladder bowel dysfunction", Urol Clin North Am, 45, pp.633~640 (2018)
2. Akiyama Y, "Pathology and terminology of interstitial cystitis", bladder pain syndrome: a review, 2019, pp.34, 25~32
3. Costantini E, "Urological dysfunction in young women : an inheritance of childhood", BJU Int, 121, pp.453~457 (2018)
4. Abramov Y, "Eosinophilic cystitis after bladder instillation with dimethyl sulfoxide", Urology, 63, pp.1182~1183 (2004)
5. Abrams P, "Recommendations of the International Scientific Committee: Evaluation and treatment of urinary incontinence, pelvic organ prolapse and faecal incontinence", Neurourol Urodyn, 37, pp.2271~2272 (2018)
6. Abelha-Aleixo J, "Lupus cystitis and repercussions of delayed diagnosis", Acta Reumatol Port, 40, pp.294~298 (2015)
7. Akiyama Y, "Digital quantitative analysis of mast cell infiltration in interstitial cystitis", Neurourol Urodyn, 37, pp.650~657 (2018)
8. Allen-Brady K, "significant linkage evidence for interstitial cystitis", painful bladder syndrome on chromosome 3, 2018, pp.199, 172~177
9. Clemens JQ, "Correlates of health care seeking activities in patients with urological chronic pelvic pain syndromes : findings from the MAPP cohort", J Urol, 200, pp.136~140 (2018)
10. Clemens JQ, "Urologic chronic pelvic pain syndrome : insights from the MAPP Research Network", Nat Rev Urol, 16, pp.187~200 (2019)
11. Cox A, "CUA guideline : diagnosis and treatment of interstitial cystitis", bladder pain syndrome, 2016, pp.10, E136~E155
12. Crescenze IM, "Efficacy, side effects, and monitoring of oral cyclosporine in interstitial cystitisbladder pain syndrome", Urology, 107, pp.49~54 (2017)
13. Doiron RC, "Childhood bladder and bowel dysfunction predicts irritable bowel syndrome phenotype in adult interstitial cystitis", bladder pain syndrome patients, 2017, pp.11, 255~259
14. Gardella B, "Interstitial cystitis is associated with vulvodynia and sexual dysfunction--a case-control study", J Sex Med, 8, pp.1726~1734 (2011)
15. Grigorescu B, "Update on urinary tract markers in interstitial cystitis", bladder pain syndrome, 2016, pp.22, 16~23
16. Akiyama Y, "Extent of Hunner lesions : the relationships with symptom severity and clinical parameters in Hunner type interstitial cystitis patients", Neurourol Urodyn, 37, pp.1441~1447 (2018)
17. Chen MH, "Cognitive function of patients with treatment-resistant depression after a single low dose of ketamine infusion", J Affect Disord, 241, pp.1~7 (2018)
18. Peters KM, "Bladder pain syndrome– an evolution", pp.131~133 (2018), Springer International Publishing
19. Friedlander JI, "Diet and its role in interstitial cystitis", bladder pain syndrome(IC, BJU Int, pp.2012, 109[DOI]
20. Agarwal MM, "Gabapentenoids in pain management in urological chronic pelvic pain syndrome : Gabapentin or pregabalin", Neurourol Urodyn, 36, pp.2028~2033 (2017)
21. Funaro MG, "Endoscopic injection of low dose triamcinolone: a simple, minimally invasive, and effective therapy for interstitial cystitis with Hunner lesions", Urology, 118, pp.25~29 (2018)
22. Gabriela E. Halder, "Botox combined with myofascial release physical therapy as a treatment for myofascial pelvic pain", Investigative and Clinical Urology, 58(2), pp.134~139 (2017), 대한비뇨의학회[DOI]
23. Henry RA, "Beyond a simple anesthetic effect : lidocaine in the diagnosis and treatment of interstitial cystitis", bladder pain syndrome, 2015, pp.85, 1025~1033
24. Hoke TP, "Hydrodistention of the bladder for the treatment of bladder pain syndrome", interstitial cystitis(BPS, Neurourol Urodyn, pp.2017, 36[DOI]
25. Kirk PS, "The effects of cystoscopy and hydrodistention on symptoms and bladder capacity in interstitial cystitis", bladder pain syndrome, 2018, pp.37, 2002~2007
26. Gamper M, "Are mast cells still good biomarkers for bladder pain syndrome", interstitial cystitis, 2015, pp.193, 1994~2000
27. Ichihara K, "Toll-like receptor 7 is overexpressed in the bladder of Hunner-type interstitial cystitis, and its activation in the mouse bladder can induce cystitis and bladder pain", Pain, 158, pp.1538~1545 (2017)
28. Kim A, "Histopathological characteristics of interstitial cystitis", bladder pain syndrome without Hunner lesion, 2017, pp.71, 415~424
29. Maeda D, "Hunner-type(classic)interstitial cystitis : a distinct inflammatory disorder characterized by pancystitis, with frequent expansion of clonal B-cells and epithelial denudation", PLoS One, 10, pp.e0143316~ (2015)
30. Krieger JN, "Relationship between chronic nonurological associated somatic syndromes and symptom severity in urological chronic pelvic pain syndromes : baseline evaluation of the MAPP study", J Urol, 193, pp.1254~1262 (2015)
31. Lai HH, "Painful bladder filling and painful urgency are distinct characteristics in men and women with urological chronic pelvic pain syndromes : a MAPP research network study", J Urol, 194, pp.1634~1641 (2015)
32. Landis JR, "The MAPP research network: design, patient characterization and operations", BMC Urol, 14, pp.58~ (2014)
33. Shim SR, "Efficacy and safety of botulinum toxin injection for interstitial cystitis", bladder pain syndrome : a systematic review and meta-analysis, 2016, pp.48, 1215~1227
34. Sutcliffe S, "Urological chronic pelvic pain syndrome symptom flares : characterisation of the full range of flares at two sites in the multidisciplinary approach to the study of chronic pelvic pain(MAPP)research network", BJU Int, 114, pp.916~925 (2014)
35. Sutcliffe S, "A case-crossover study of urological chronic pelvic pain syndrome flare triggers in the MAPP research network", J Urol, 199, pp.1245~1251 (2018)
36. Jhang JF, "Possible pathophysiology of ketaminerelated cystitis and associated treatment strategies", Int J Urol, 22, pp.816~825 (2015)
37. Misra S, "Ketamine-associated bladder dysfunction—a review of the literature", Curr Bladder Dysfunct Rep, 13, pp.145~152 (2018)
38. Zeng J, "Effective treatment of ketamine-associated cystitis with botulinum toxin type a injection combined with bladder hydrodistention", J Int Med Res, 45, pp.792~797 (2017)
39. Gauney G, "Ketamine : its use and abuse in urological practice", AUA Update Series, 35, pp.287~296 (2016)
40. Chuang YC, "A prospective, multicenter, double-blind, randomized trial of bladder instillation of liposome formulation onabotulinumtoxinA for interstitial cystitis", bladder pain syndrome, 2017, pp.198, 376~382
41. Pinto RA, "Intratrigonal onabotulinumtoxinA improves bladder symptoms and quality of life in patients with bladder pain syndrome", interstitial cystitis: a pilot, single center, randomized, double-blind, placebo controlled trial, 2018, pp.199, 998~1003
42. Rawls WF, "Dimethyl sulfoxide(DMSO)as intravesical therapy for interstitial cystitis", bladder pain syndrome : a review, 2017, pp.36, 1677~1684
43. Tomoe H, "In what type of interstitial cystitis", bladder pain syndrome is DMSO intravesical instillation therapy effective?, 2015, pp.4, 600~604
44. Gupta P, "A multidisciplinary approach to the evaluation and management of interstitial cystitis", bladder pain syndrome : an ideal model of care, 2015, pp.4, 611~619
45. Kuo YC, "Videourodynamic characteristics of interstitial cystitis", bladder pain syndrome-The role of bladder outlet dysfunction in the pathophysiology, 2018, pp.37, 1971~1977
46. Kuo TL, "Pelvic floor spasm as a cause of voiding dysfunction", Curr Opin Urol, 25, pp.311~316 (2015)
47. Nickel JC, "FDA BRUDAC 2018 Criteria for interstitial cystitis", bladder pain syndrome clinical trials : future direction for research, 2018, pp.200, 39~42
48. Walker SJ, "Bladder capacity is a biomarker for a bladder centric versus systemic manifestation in interstitial cystitis", bladder pain syndrome, 2017, pp.198, 369~375
49. Patnaik SS, "Etiology, pathophysiology and biomarkers of interstitial cystitis", painful bladder syndrome, 2017, pp.295, 1341~1359
50. Chai TC, "Bladder stretch alters urinary heparin-binding epidermal growth factor and antiproliferative factor in patients with interstitial cystitis", J Urol, 163, pp.1440~1444 (2000)
51. Regauer S, "Sensory hyperinnervation distinguishes bladder pain syndrome", interstitial cystitis from overactive bladder syndrome, 2017, pp.197, 159~166
52. Theoharides TC, "Urological and gynaecological chronic pelvic pain", pp.153~163 (2017), Springer International Publishing
53. Vera PL, "Elevated urine levels of macrophage migration inhibitory factor in inflammatory bladder conditions : a potential biomarker for a subgroup of interstitial cystitis", bladder pain syndrome patients, 2018, pp.116, 55~62
54. Muere A, "Depression and coping behaviors are key factors in understanding pain in interstitial cystitis", bladder pain syndrome, 2018, pp.19, 497~505
55. Manning J, "A multicentre, prospective, randomised, double-blind study to measure the treatment effectiveness of abobotulinum A (AboBTXA)among women with refractory interstitial cystitis", bladder pain syndrome, 2014, pp.25, 593~599
56. Morrissey D, "Botulinum toxin A injections into pelvic floor muscles under electromyographic guidance for women with refractory high-tone pelvic floor dysfunction : a 6-month prospective pilot study", Female Pelvic Med Reconstr Surg, 21, pp.277~282 (2015)
57. Olson LE, "A systematic review of the literature on cystodistension in bladder pain syndrome", Int Urogynecol J, 29, pp.251~257 (2018)
58. Rahnama’i MS, "The efficacy of botulinum toxin A and sacral neuromodulation in the management of interstitial cystitis (IC)", bladder pain syndrome (BPS), what do we know? ICI-RS 2017 think thank, Bristol, 2018, pp.37(S4), S99~S107
59. Redmond EJ, "The role of reconstructive surgery in patients with end-stage interstitial cystitis", bladder pain syndrome : is cystectomy necessary, 2017, pp.28, 1551~1556
60. Chai TC, "Percutaneous sacral third nerve root neurostimulation improves symptoms and normalizes urinary HB-EGF levels and antiproliferative activity in patients with interstitial cystitis", Urology, 55, pp.643~646 (2000)
61. Moldwin RM, "Bladder pain syndrome – an evolution", pp.115~119 (2018), Springer International Publishing
62. Pearce WA, "Pigmentary maculopathy associated with chronic exposure to pentosan polysulfate sodium", Ophthalmology, 125, pp.1793~1802 (2018)
63. Rubin RS, "Interstitial cystitis and sexual dysfunction : diagnostic accuracy is essential", Curr Sex Health Rep, 10, pp.104~108 (2018)
64. Santos JD, "Bladder and bowel dysfunction in children: an update on the diagnosis and treatment of a common, but underdiagnosed pediatric problem", Can Urol Assoc J, 11(1-2Suppl1), pp.S64~S72 (2017)
65. Han E, "Current best practice management of interstitial cystitis", bladder pain syndrome, 2018, pp.10, 197~211

관련 논문AI추천